 |
 |
Maria Jose Alonso (Universidad de Santiago de Compostela, Spain)
|
|
|
 |
Pedro Alpuim (INL, Portugal)
|
|
|
 |
Giuseppe Battaglia (IBEC, Spain)
|
|
|
 |
Ofra Benny (The Hebrew University of Jerusalem, Israel)
|
|
|
 |
Gianni Ciofani (IIT, Italy)
Patient-specific nanovectors against glioblastoma multiforme
|
|
|
 |
Cristina Fornaguera Puigvert (Universidad Ramon Llull, Spain)
pBAE polymers: a new delivery platform of biologicals for nucleic acid-based therapies
|
; ?>) |
|
 |
Laura Gonzalez Macia (Imperial College London, UK)
|
|
|
 |
Laura Lechuga (ICN2, Spain)
|
|
|
 |
Ramón Martínez Mañez (UPV, Spain)
|
|
|
 |
Sergio Moya (CIC BiomaGUNE, Spain)
|
|
|
 |
Danny Porath (The Hebrew University of Jerusalem, Israel)
|
|
|
 |
Carlotta Pucci (IIT, Italy)
Unveiling the Promise of Personalized Therapy: Harnessing Cell Membrane-Coated Nanovectors for Targeted Treatment of Glioblastoma Multiforme
|
|
|
 |
César Rodriguez-Emmenegger (IBEC, Spain)
Bridging Medicine with Bioinspired Systems, Nanocoatings and Synthetic Cells
|
|
|
 |
Samuel Sanchez (IBEC, Spain)
Treating bladder cancer with self-propelled nanobots
|
|
|
 |
Félix Sauvage (Ghent University, Belgium)
Laser-induced nanobubbles for advanced therapies in the eye
|
|
|
 |
Avi Schroeder (Technion, Israel)
|
|
|
 |
Nicola Tirelli (IIT, Italy)
On hyaluronic acid and the (poor) understanding of its interactions with cell receptors
|
|
|
 |
Alexander Zelikin (Aarhus University, Denmark)
Artificial receptors and signaling cascades in synthetic cells
|
|
|
